HK1172026A1 - Etomidate analogues that do not inhibit adrenocortical steroid synthesis - Google Patents

Etomidate analogues that do not inhibit adrenocortical steroid synthesis

Info

Publication number
HK1172026A1
HK1172026A1 HK12112892.0A HK12112892A HK1172026A1 HK 1172026 A1 HK1172026 A1 HK 1172026A1 HK 12112892 A HK12112892 A HK 12112892A HK 1172026 A1 HK1172026 A1 HK 1172026A1
Authority
HK
Hong Kong
Prior art keywords
steroid synthesis
adrenocortical steroid
inhibit
etomidate analogues
etomidate
Prior art date
Application number
HK12112892.0A
Other languages
English (en)
Chinese (zh)
Inventor
約瑟夫．
．科藤
道格拉斯．
．雷恩斯
斯圖爾特．
．福曼
基思．
．米勒
賽德．
．侯賽因
格雷戈裏．
．屈尼
Original Assignee
通用醫療公司
布裏格姆及婦女醫院股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 通用醫療公司, 布裏格姆及婦女醫院股份有限公司 filed Critical 通用醫療公司
Publication of HK1172026A1 publication Critical patent/HK1172026A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Steroid Compounds (AREA)
HK12112892.0A 2009-07-10 2012-12-13 Etomidate analogues that do not inhibit adrenocortical steroid synthesis HK1172026A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22475109P 2009-07-10 2009-07-10
PCT/US2010/041379 WO2011005969A2 (en) 2009-07-10 2010-07-08 Etomidate analogues that do not inhibit adrenocortical steroid synthesis

Publications (1)

Publication Number Publication Date
HK1172026A1 true HK1172026A1 (en) 2013-04-12

Family

ID=43429834

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12112892.0A HK1172026A1 (en) 2009-07-10 2012-12-13 Etomidate analogues that do not inhibit adrenocortical steroid synthesis

Country Status (10)

Country Link
US (2) US8765973B2 (xx)
EP (1) EP2451779B1 (xx)
JP (1) JP5925121B2 (xx)
CN (1) CN102548964B (xx)
AU (1) AU2010271345B2 (xx)
BR (1) BR112012000606A2 (xx)
CA (1) CA2767112C (xx)
HK (1) HK1172026A1 (xx)
RU (1) RU2559888C2 (xx)
WO (1) WO2011005969A2 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9156825B2 (en) * 2012-01-13 2015-10-13 The General Hospital Corporation Anesthetic compounds and related methods of use
SG10201705852PA (en) * 2012-11-14 2017-08-30 Teijin Pharma Ltd Pyridine derivative
JP2017531011A (ja) 2014-10-16 2017-10-19 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ 麻酔のための新規の方法、化合物および組成物
CA3001128A1 (en) 2015-10-07 2017-04-13 Apellis Pharmaceuticals, Inc. Use of long-acting compstatin analog for treating a complement-mediated eye disorder
HUE058909T2 (hu) * 2015-10-10 2022-09-28 Jiangsu Nhwaluokang Pharmceutical Res And Development Co Ltd Etomidátszármazék és köztitermék, eljárás elõállítására és alkalmazása
CN107445898A (zh) * 2016-05-30 2017-12-08 四川海思科制药有限公司 N‑取代咪唑羧酸酯类化合物及其制备方法和在医药上的用途
CN107522662A (zh) * 2016-06-16 2017-12-29 四川海思科制药有限公司 N‑取代咪唑羧酸酯类化合物及其制备方法和在医药上的用途
CN107641105A (zh) * 2016-07-22 2018-01-30 四川海思科制药有限公司 N‑取代咪唑羧酸酯类化合物及其制备方法和在医药上的用途
CN107652239B (zh) * 2017-02-24 2020-08-04 四川大学华西医院 N-取代咪唑羧酸酯类化合物、制备方法及用途
KR20190139931A (ko) 2017-04-07 2019-12-18 아펠리스 파마슈티컬스 인코포레이티드 투여 요법 및 관련 조성물 및 방법
CN116120295A (zh) 2018-01-30 2023-05-16 成都麻沸散医药科技有限公司 一种n-取代咪唑甲酸酯类衍生物及其用途
CN110003188B (zh) * 2019-03-27 2022-08-26 成都麻沸散医药科技有限公司 取代吡咯甲酸酯类衍生物及其用途
CN110669017B (zh) * 2019-10-11 2023-08-04 成都麻沸散医药科技有限公司 多取代三唑甲酸酯类衍生物及其用途
CN112174890B (zh) * 2020-10-09 2022-05-27 成都麻沸散医药科技有限公司 酮取代杂环化合物及其麻醉作用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3354173A (en) 1964-04-16 1967-11-21 Janssen Pharmaceutica Nv Imidazole carboxylates
US4038286A (en) 1975-03-10 1977-07-26 Janssen Pharmaceutica N.V. Racemates and optical isomers of 1-(1-phenylethyl)-1h-imidazole-5-carboylic acid derivatives
GR64915B (en) 1978-09-14 1980-06-09 Janssen Pharmaceutica Nv Improved etomidate-containing compositions
US4878940A (en) 1987-04-02 1989-11-07 Janssen Pharmaceutica N.V. Herbicidal 1,5-substituted 1H-imidazoles
US5041554A (en) * 1989-01-31 1991-08-20 Merrell Dow Pharmaceuticals Inc. Novel aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions
AU629290B2 (en) * 1989-01-31 1992-10-01 Merrell Dow Pharmaceuticals Inc. Novel aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions
US5019583A (en) 1989-02-15 1991-05-28 Glaxo Inc. N-phenyl-N-(4-piperidinyl)amides useful as analgesics
US5242939A (en) * 1990-09-28 1993-09-07 Warner-Lambert Company Anilide derivatives with angiotensin ii antagonist properties
JP3374922B2 (ja) 1991-05-09 2003-02-10 日産化学工業株式会社 複素環式第３級アミンの製造方法
JPH06345728A (ja) 1993-06-11 1994-12-20 Nissan Chem Ind Ltd Ｎ−置換アゾール誘導体の製造方法
US5466700A (en) 1993-08-30 1995-11-14 Glaxo Wellcome Inc. Anesthetic use of N-phenyl-N-(4-piperidinyl)amides
US5756528A (en) 1995-06-06 1998-05-26 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
RU2160265C1 (ru) * 2000-03-17 2000-12-10 Научно-исследовательский институт физической и органической химии Ростовского государственного университета Дигидрохлорид 1-(3-пирролидинопропил)-2-фенилимидазо [1,2-а]-бензимидазола, обладающий местноанестезирующим действием
EP1383445A4 (en) 2001-03-20 2005-04-13 Cydex Inc PREPARATION CONTAINING PROPOFOL AND SULFOALKYL ETHER CYCLODEXTRIN
ATE359783T1 (de) * 2001-12-27 2007-05-15 Ortho Mcneil Pharm Inc Aroylpyrrolheteroeryl und methanole zur behandlung von störungen des zentralnervensystems
WO2006023844A2 (en) 2004-08-20 2006-03-02 Entremed, Inc. Compositions and methods comprising proteinase activated receptor antagonists
AU2009251659B2 (en) * 2008-03-31 2013-07-11 The General Hospital Corporation Etomidate analogues with improved pharmacokinetic and pharmacodynamic properties

Also Published As

Publication number Publication date
AU2010271345B2 (en) 2014-12-04
JP5925121B2 (ja) 2016-05-25
US20130079381A1 (en) 2013-03-28
EP2451779A2 (en) 2012-05-16
EP2451779A4 (en) 2013-04-24
EP2451779B1 (en) 2014-09-03
WO2011005969A3 (en) 2011-05-12
CA2767112C (en) 2018-06-19
CN102548964A (zh) 2012-07-04
BR112012000606A2 (pt) 2016-11-22
WO2011005969A2 (en) 2011-01-13
US8765973B2 (en) 2014-07-01
CN102548964B (zh) 2014-09-24
RU2012104761A (ru) 2013-08-20
US9187421B2 (en) 2015-11-17
JP2012532883A (ja) 2012-12-20
US20150011603A1 (en) 2015-01-08
AU2010271345A1 (en) 2012-02-02
CA2767112A1 (en) 2011-01-13
RU2559888C2 (ru) 2015-08-20

Similar Documents

Publication Publication Date Title
HK1172026A1 (en) Etomidate analogues that do not inhibit adrenocortical steroid synthesis
HK1205543A1 (en) Flush toilet
AP3286A (en) Glucagon analogues
AP2013006671A0 (en) Glucagon analogues
HRP20160887T1 (hr) Formulacije testosterona
EP2640900A4 (en) IMPACT CUSHION
GB0905538D0 (en) Aircraft seat
GB201103545D0 (en) Retractor
EP2634360A4 (en) LOCKING STRUCTURE FOR AN EXTENDABLE LADDER
EP2407476A4 (en) STEROID COMPOUND
EP2613644A4 (en) STABILIZED FOAM
EP2492154A4 (en) AIRBAG
PL2473549T3 (pl) Sposób otrzymywania fluorokarbofunkcyjnych silseskwioksanów
GB2481675B (en) Harness
PL2468141T3 (pl) Siedzisko trybunowe
EP2565192A4 (en) CANCER AGENT
GB2481325B (en) Restraining harnesses
ZA201200489B (en) Steroid solvates
GB201004491D0 (en) Quinazoline analogues
GB0918087D0 (en) Emergency harness
ZA201205583B (en) Retractor
GB201004253D0 (en) Wiring harness
GB201012577D0 (en) Bagpipe harness
GB201011109D0 (en) Nucleoside analogues as potential anti-malarials
TWM385622U (en) Structure for divider

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190704